Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 26,608 shares at $399.41 ($10.6M) on 2023-12-13, disclosed to the SEC on 2023-12-15.
Scheduled sale ($10.6M) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $399.41 | 13,254 | $5.3M | 49.8% |
| 2 | $399.41 | 13,254 | $5.3M | 49.8% |
| 3 | $400.19 | 100 | $40K | 0.4% |
| Total | $399.41 avg | 26,608 | $10.6M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |